Related Experiment Videos
Revascularization in severe left ventricular dysfunction: the role of viability testing.
Panithaya Chareonthaitawee1, Bernard J Gersh, Philip A Araoz
1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA. chareonthaitawee.panithaya@mayo.edu
Journal of the American College of Cardiology
|August 16, 2005
Summary
Revascularization may help patients with ischemic cardiomyopathy, but optimal strategies remain uncertain due to limited evidence and higher risks. Identifying suitable candidates using viability testing is key for better outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Imaging
Background:
- Ischemic cardiomyopathy (ICM) affects many patients, with revascularization as a potential treatment.
- Current treatment strategies for ICM lack definitive guidance due to limited high-quality evidence and procedural risks.
- Uncertainty exists regarding the optimal approach for managing moderate-to-severe ICM.
Purpose of the Study:
- To review the existing literature on revascularization outcomes in ICM.
- To evaluate the role of noninvasive viability testing in patient selection.
- To identify patient subsets who may benefit most from revascularization therapy.
Main Methods:
- Systematic review of published literature.
- Analysis of studies reporting outcomes after revascularization in ICM patients.
- Assessment of the predictive value of noninvasive viability tests.
Main Results:
- The literature on revascularization for ICM is limited by a lack of completed randomized trials.
- Periprocedural risks associated with revascularization contribute to treatment uncertainty.
- Noninvasive viability testing may help identify patients likely to benefit from therapy.
Conclusions:
- Revascularization is a viable option for select patients with moderate-to-severe ICM.
- Further randomized controlled trials are needed to clarify optimal treatment strategies.
- Noninvasive viability assessment is crucial for personalized treatment decisions in ICM.